
Currently, Glenmark’s portfolio consists of 175 products authorized for distribution in the U.S. marketplace and 48 ANDAs pending approval with…
According to a statement, the collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable…
Although it can not be established if this investment into Wockhardt is Rakesh Jhunjhunwala’s initial purchase of the firm’s stocks,…
Wockhardt in a BSE filing said that the manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based…
Amtek Auto Shares ended 5.63 per cent down at Rs 27.65 after the company reported net loss of Rs 132.15…
According to the company, half of the issues will be resolved in next fortnight The nine observations received by Wockhardt…
The facility, which produces various products including ointments, capsules and tablets, currently caters to the UK and Ireland markets.
The USFDA has made nine ‘observations’ highlighting violations of its norms at homegrown drug maker Wockhardt’s new facility at Shendra…
Wockhardt shares fell as much as 12.69 per cent intraday on Friday on reports the company has received a notice…
WCK 5222 is a new class of antibiotic for gram negative terrain for complicated urinary tract infections and HABP/ VABP…
Drug maker Wockhardt has received qualified disease product (QIDP) status from US health regulator for a new antibiotic.
The UK regulator had in October 2013 withdrawn the GMP certificate to the Chikalthana plant Wockhardt’s Chikalthana plant at Aurangabad…
The three products have been classified as new drugs and thus qualify for non-application of the DPCO 2013 Drug price…
Wockhardt had applied to the National Pharmaceutical Pricing Authority (NPPA) for non-application of price control provisions of the DPCO 2013…
EBIDTA was at Rs 201 crore
Wockhardt today reported a multi-fold jump in consolidated net profit at Rs 107.59 crore for the second quarter ended September…
Wockhardt shares were trading over 2 per cent up after the company said that UK’s health regulator Medicines and Healthcare…
The double-digit stock market gains of Indian pharmaceutical giants including Dr. Reddy’s Laboratories and Wockhardt stand out in stark relief…
Sun Pharma’s recall was initiated last month under Class-III classification while Wockhardt’s recall was under class-II classification Sun Pharma and…
EBIDTA is up by 165 per cent at Rs 167 crore Wockhardt has posted its first quarter results for financial…
Wockhardt is recalling over 50 lakh bottles of various drugs, used for treating ailments like high blood pressure and ulcer.
Drug firm Wockhardt is recalling 1,62,142 cartons of various drugs, which are used to treat ailments like high blood pressure…
Loading…
Something went wrong. Please refresh the page and/or try again.